Abstract [Download PDF] [Read Full Text]
Neurotrophic keratopathy (NK) is a relatively rare degenerative corneal disease.Over time, it can cause varying degrees of ocular surface damage, leading to corneal ulcers, perforations and even blindness.The best opportunity to reverse ocular surface damage is in the earliest stage of NK.However, patients experience few typical symptoms and diagnosis is often delayed.In 2021, BMC Ophthalmology published the Expert Consensus on the Identification, Diagnosis and Treatment of Neurotrophic Keratopathy in Volume 21.Through the interpretation of the consensus, this paper hopes to further improve ophthalmologists’ understanding of the screening and treatment of NK, and optimize the management norms of NK diagnosis and treatment.
Key words:
Contributor Information
Department of Ophthalmology, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China
Department of Ophthalmology, Jinshan District Hospital Affiliated to Fudan University, Shanghai 201500, China
Department of Ophthalmology, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China